Milestone Pharmaceuticals Inc.
0 products tracked · names used in filings: Milestone Pharmaceuticals Inc.
Upcoming milestones
No upcoming milestones listed.
Recent milestones
CARDAMYST: PDUFA target action date (paroxysmal supraventricular tachycardia (PSVT))
Milestone Pharmaceuticals Inc. (MIST); etripamil; NDA; status: set; "Exhibit 99.1 Milestone Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Regulatory and Corporate Update PDUFA Target Date of December 13, 2025 for CARDAMYST™ (etripamil) Nasal Spray in Paroxysmal Supraventricular Tachycardia (PSVT) Promotional Launch Plans Set w"; filed 2025-11-12 · source
Products
No products recorded.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.